NHLRC3 antibody (FITC)

Catalog No. ABIN1402118

Product Details anti-NHLRC3 Antibody (FITC)

Target: NHLRC3 (NHL Repeat Containing 3 (NHLRC3))

Reactivity: Human, Mouse, Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: This NHLRC3 antibody is conjugated to FITC

Application: Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Cross-Reactivity: Human, Mouse, Rat

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human NHLRC3

Isotype: IgG

Application Details

Application Notes: IF(IHC-P) 1:50-200

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Expiry Date: 12 months

Target Details for NHLRC3

Target: NHLRC3 (NHL Repeat Containing 3 (NHLRC3))

Alternative Name: NHLRC3 (NHLRC3 Products)

Synonyms: 4833441N19 antibody, 8030451K01Rik antibody, mKIAA4083 antibody, RGD1565414 antibody, NHL repeat containing 3 antibody, NHLRC3 antibody, Nhlrc3 antibody

Background:

Synonyms: DKFZp313M1221, DKFZp686E1140, NHL repeat containing 3, NHL repeat containing protein 3, NHLRC 3, NHLC3_HUMAN.

Background: NHLRC3 contains 4 NHL repeats. The function of the NHLRC3 protein remains unknown. Key tumor suppressor genes on chromosome 13 include the breast cancer susceptibility gene, BRCA2, and the RB1 (retinoblastoma) gene. RB1 encodes a crucial tumor suppressor protein which, when defective, leads to malignant growth in the retina and has been implicated in a variety of other cancers. The gene SLITRK1, which is associated with Tourette syndrome, is on chromosome 13. As with most chromosomes, polysomy of part or all of chromosome 13 is deleterious to development and decreases the odds of survival. Trisomy 13, also known as Patau syndrome, is quite deadly and the few who survive past one year suffer from permanent neurologic defects, difficulty eating and vulnerability to serious respiratory infections.